Gainers
- Catheter Precision VTAK shares moved upwards by 232.2% to $0.75 during Wednesday's regular session. The company's market cap stands at $8.2 million.
- Nuwellis NUWE stock rose 85.26% to $0.43. The market value of their outstanding shares is at $1.8 million.
- Kazia Therapeutics KZIA shares moved upwards by 79.81% to $9.45. The market value of their outstanding shares is at $52.8 million.
- Helius Medical Tech HSDT stock rose 74.08% to $1.47.
- Kindly MD NAKA stock increased by 66.75% to $19.34. The company's market cap stands at $144.2 million.
- NanoVibronix NAOV shares moved upwards by 58.57% to $1.29. The market value of their outstanding shares is at $3.3 million.
Losers
- CARISMA Therapeutics CARM stock fell 46.7% to $0.59 during Wednesday's regular session. The market value of their outstanding shares is at $24.7 million.
- XOMA Royalty XOMAP stock fell 34.68% to $16.71.
- Liminatus Pharma LIMN stock decreased by 33.99% to $14.8. The company's market cap stands at $385.0 million.
- Rafael Holdings RFL shares decreased by 26.85% to $2.08. The company's market cap stands at $77.6 million. As per the news, the Q3 earnings report came out today.
- Cabaletta Bio CABA stock declined by 26.18% to $1.74. The market value of their outstanding shares is at $88.0 million.
- Adial Pharmaceuticals ADIL shares declined by 21.35% to $0.47. The company's market cap stands at $3.6 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
ADILAdial Pharmaceuticals Inc
$0.3922-0.58%
Edge Rankings
Momentum
4.50
Price Trend
Short
Medium
Long
CABACabaletta Bio Inc
$1.671.21%
CARMCARISMA Therapeutics Inc
$0.29102.00%
HSDTHelius Medical Technologies Inc
$5.90-1.99%
KZIAKazia Therapeutics Ltd
$7.89-4.59%
LIMNLiminatus Pharma Inc
$4.05-1.70%
NAKAKindly MD Inc
$13.87-7.69%
NAOVNanoVibronix Inc
$6.35-5.51%
NUWENuwellis Inc
$5.39-4.39%
RFLRafael Holdings Inc
$1.652.48%
VTAKCatheter Precision Inc
$2.58-11.8%
XOMAPXOMA Royalty Corp
$16.71-35.1%
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.